Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShort-Term Debt repayments
Ratios

Fortress Biotech (FBIO) Depreciation & Amortization (IS): 2016-2018

Historic Depreciation & Amortization (IS) for Fortress Biotech (FBIO) over the last 2 years, with Sep 2018 value amounting to $871,000.

  • Fortress Biotech's Depreciation & Amortization (IS) rose 71.79% to $871,000 in Q3 2018 from the same period last year, while for Sep 2018 it was $3.2 million, marking a year-over-year increase of 53.69%. This contributed to the annual value of $2.1 million for FY2017, which is 283.30% up from last year.
  • As of Q3 2018, Fortress Biotech's Depreciation & Amortization (IS) stood at $871,000, which was up 1.63% from $857,000 recorded in Q2 2018.
  • In the past 5 years, Fortress Biotech's Depreciation & Amortization (IS) registered a high of $871,000 during Q3 2018, and its lowest value of $500,000 during Q2 2017.
  • Its 3-year average for Depreciation & Amortization (IS) is $652,625, with a median of $560,500 in 2016.
  • Data for Fortress Biotech's Depreciation & Amortization (IS) shows a peak YoY skyrocketed of 71.79% (in 2018) over the last 5 years.
  • Quarterly analysis of 3 years shows Fortress Biotech's Depreciation & Amortization (IS) stood at $545,000 in 2016, then climbed by 5.69% to $576,000 in 2017, then surged by 71.79% to $871,000 in 2018.
  • Its Depreciation & Amortization (IS) stands at $871,000 for Q3 2018, versus $857,000 for Q2 2018 and $859,000 for Q1 2018.